Human hantavirus diseases – still neglected zoonoses?

Česká verzia

Authors: V. Vrbovská ^1,2; P. Chalupa ³; P. Straková ^1,2; Z. Hubálek ^1,2 ; I. Rudolf ^1,2
Authors place of work: Ústav experimentální biologie, Masarykova univerzita, Brno ¹; Ústav biologie obratlovců AV ČR, v. v. i., Brno ²; Klinika infekčních nemocí, 1. LF UK v Praze a Ústřední vojenská nemocnice – Vojenská fakultní nemocnice Praha ³
Published in the journal: Epidemiol. Mikrobiol. Imunol. 64, 2015, č. 4, s. 188-196
Category: Review Article

Summary

Hantavirus disease is the most common rodent-borne viral infection in the Czech Republic, with a mean annual incidence of 0.02 cases per 100 000 population and specific antibodies detected in 1% of the human population. Four hantaviruses (Puumala, Dobrava-Belgrade, Tula, and Seewis) circulate in this country, of which Puumala virus (responsible for a mild form of hemorrhagic fever with renal syndrome called nephropathia epidemica) and Dobrava-Belgrade virus (causing haemorrhagic fever with renal syndrome) have been proven to cause human disease. The aim of this study is to provide a comprehensive review of the hantaviruses occurring in the Czech Republic, based on the literature published during the past three decades, including their geographical distribution and clinical symptoms. The recent detection of Tula virus in an immunocompromised person as well as reports of Seoul virus infections in Europe highlight the possible emergence of neglected hantavirus infections in the foreseeable future.

Keywords:
hantaviruses – Dobrava-Belgrade – Puumala – rodents – insectivores – emerging diseases –surveillance

Zdroje

1. Vapalahti O, Mustonen J, Lundkvist A, et al. Hantavirus infections in Europe. Lancet Inf Dis, 2003; 3:653–661.

2. Gratz N. Vector- and Rodent-borne Diseases in Europe and North America: Their Distribution and Public Health. Cambridge: Cambridge Univ. Press; 2006.

3. Lee HW, Lee PW, Johnson KM. Isolation of etiologic agent of Korean hemorrhagic fever. J Infect Dis, 1978; 137:298–308.

4. Jonsson CB, Figueiredo LTM, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev, 2010; 23:412–441.

5. Avsic-Zupanc T, Saksida A, Korva M. Hantavirus infections. Clin Microbiol Infect, 2013; doi: 10.1111/1469-0691.12291.

6. Jenison S, Yamada T, Morris C, et al. Characterization of human antibody responses to Four Corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol, 1994; 68:3000–3006.

7. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science, 1993; 262:914–917.

8. Maupin G, Gage K, Childs JE, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg, 1994; 5:102–108.

9. Childs JE, Ksiazek TG, Spiropoulou CF, et al. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis, 1994; 169:1271–1280.

10. Hjelle B, Torres-Perez F. Hantaviruses in the Americas and their role as emerging pathogens. Viruses-Basel, 2010; 2:2559–2586.

11. CDC, MMWR. Annual U.S. HPS Cases and Case-fatality, 1993–2013. Dostupné na www: www.cdc.gov/hantavirus/surveillance/annual-cases.html.

12. Charrell RN, Coutard B, Baronti C, et al. Arenaviruses and hantaviruses: From epidemiology and genomics to antivirals. Antiviral Res, 2011; 90:102–114.

13. Peters CJ, Mills JN, Spiropoulou C, et al. Hantavirus infections. In: Guerrant RL, Walker DH, Weller PF. Tropical Infectious Diseases: Principles, Pathogens & Practice Philadelphia: Elsevier; 2006.

14. Lednicky JA. Hantaviruses: A short review. Arch Pathol Lab Med, 2003; 127:30–35.

15. Kruger DH, Schonrich G, Klempa B. Human pathogenic hantaviruses and prevention of infection. Hum Vaccines, 2011; 7:685–693.

16. Hepojoki J, Strandin T, Lankinen H, Vaheri A. Hantavirus structure-molecular interactions behind the scene. J Gen Virol, 2012; 93:1631–1644.

17. Safronetz D, Zivcec M, LaCasse R, et al. Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog, 2011; 7:1–15.

18. Plyusnin A, Vapalahti O, Vaheri A. Hantaviruses: Genome structure, expression and evolution. J Gen Virol, 1996; 77:2677–2687.

19. Taylor SL, Frias-Staheli N, Garcia-Sastre A, Schmaljohn CS. Hantaan virus nucleocapsid protein binds to import in α proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. J Virol, 2009; 83:1271–1279.

20. Wells RM, Sosa Estani S, Yadon ZE, et al. An unusual hantavirus outbreak in southern Argentina: Person-to-person transmission? Emerg Infect Dis, 1997; 3:171–174.

21. Hubálek Z, Rudolf I. Microbial Zoonoses and Sapronoses. Dordrecht: Springer; 2011.

22. Klempa B, Avsic-Zupanc T, Clement J, et al. Complex evolution and epidemiology of Dobrava-Belgrade hantavirus: definition of genotypes and their characteristics. Arch Virol, 2013;158: 521–529.

23. Maes P, Klempa B, Clement J, et al. A proposal for new criteria for the classification of hantaviruses, based on S and M segment protein sequences. Infect Genet Evol, 2009; 9:813–820.

24. Young JC, Mills JN, Enria DA, et al. New World hantaviruses. Brit Med Bull, 1998;54:659–673.

25. Kang HJ, Bennett SN, Hope AG, et al. Shared ancestry between a newfound mole-borne hantavirus and hantaviruses harbored by cricetid rodents. J Virol, 2011;85:7496–7503.

26. Guo WP, Lin XD , Wang W, et al. Phylogeny and origins of hantaviruses harbored by bats, insectivores, and rodents. PLoS Pathogens, 2013;9:1–13.

27. Ling J, Sironen T, Voutilainen L, et al. Hantaviruses in finnish soricomorphs: evidence for two distinct hantaviruses carried by Sorex araneus suggesting ancient host switch. Infect Genet Evol, 2014;27:51–61.

28. Vacková M, Jebavý L, Beran J, et al. Febrilní stavy způsobené hantaviry. Prakt. lékař, 2002; 82: 84–86.

29. Pejčoch M. Hantaviry a nákazy jimi vyvolané. Klin mikrobiol inf lék 2003,1: 4–9.

30. Grešíková M, Rajčáni J, Sekeyová M, et al. Hemorrhagic fever virus with renal syndrome in small rodents in Czechoslovakia. Acta Virol, 1984;28:416–421.

31. Daneš L, Tkachenko EA, Ivanov AP, et al. Hemorrhagic fever with renal syndrome in Czechoslovakia: detection of antigen in small terrestrial mammals and specific serum antibodies in man. J Hyg Epidemiol Microbiol Immunol, 1986;30:79–85.

32. Daneš L, Pejčoch M, Hubálek Z, et al. Hantaviruses in small wild living mammals in Czechoslovakia. J Hyg Epidem 1991;35:281–288.

33. Kobzík J, Daneš L. Laboratory confirmed cases of hemorrhagic fever with renal syndrome which occured in Breclav 1989–1990. Epidemiol Microbiol Immunol, 1992;41:65–68.

34. Pejčoch M. Co to jsou hantaviry. Vesmír, 1995;74:446.

35. Pejčoch M, Kříž B. Hantaviruses in the Czech Republic. Emerg Infect Dis, 2003;9:756–757.

36. Matyášová L. Sérologický přehled hantavirových nákaz. Zprávy CEM, 1998;7:37.

37. Pejčoch M, Kříž B, Malý M. Promořenost hantaviry ve dvou oblastech s přírodními ohnisky hantavirů. Prakt lékař, 2010; 90:167–170.

38. Zelená H, Januška J. Serological characteristics of hantavirus from clinical specimens analyzed in 1998–2008 in the Department of Virology, Public Health Institute, Ostrava. Epidemiol Microbiol Imunol, 2009;58:115–120.

39. Pejčoch M, Pazdiora P, Eiselt J, et al. Seroprevalence of hantavirus antibodies among chronic hemodialysis atients in the Czech Reublic. Epidemiol Microbiol Imunol, 2010;59:48–51.

40. Vacková M, Douda P, Beran J, et al. Serologic detection of hantavirus antibodies. Epidemiol Mikrobiol Imunol, 2002;51:74–77.

41. EPIDAT (2014). Vybrané infekční nemoci v ČR v letech 2004–2014. Dostupné na www: http://www.szu.cz/publikace/data/vybrane-infekcni-nemoci-v-cr-v-letech-2003-2012-absolutne.

42. Heyman P, Ceianu C, ChristovaI, et al. A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005–2010. Eurosurveillance, 2011;16:15–22.

43. Petrů K, Pejčoch M, Monhart V, et al. Hemoragická horečka s renálním selháním. Čas Lék čes, 1997;136:739–740.

44. Papa A, Zelená H, Barnetová D, Petroušová L. Genetic detection of Dobrava/Belgrade virus in a Czech patient with haemorrhagic fever with renal syndrome. Clin Microbiol Infect, 2010;16:1187–1190.

45. Pejčoch M, Unar J, Kříž B, et al. Characterization of a natural focus of Puumala hantavirus infection in the Czech Republic, Cent Eur J Publ Health, 2010;18:116–118.

46. Dušek J, Pejčoch M, Kolský A, et al. Mild course of Puumala nephropathy in children in an area with sporadic occurrence hantavirus infection. Pediatr Nephrol, 2006, 21;1889–1992.

47. Zelená H, Zvolánková V, Zuchnická J, et al. Hantavirus infection during a stay in a mountain hut in northern Slovakia. J Med Virol, 2011;83:496–500.

48. Kruger DH, Figueiredo LTM, Song JW, Klempa B. Hantaviruses – globally emerging pathogens. J Clin Virol, 2015;64:128–136.

49. Schlegel M, Radosa L, Rosenfeld UM, et al. Broad geographical distribution and high genetic diversity of shrew-borne Seewis hantavirus in Central Europe. Virus Genes, 2012;45:48–545.

50. Heroldová M, Pejčoch M, Bryja J, et al. Tula virus in populations of small terrestrial mammals in a rural landscape. Vector-Borne Zoonotic Dis, 2010;10:599–603.

51. Plyusnin A, Cheng Y, Vapalahti O, et al. Genetic variation in Tula hantaviruses: Sequence analysis of the S and M segments of strains from Central Europe. Virus Res, 1995;39:237–250.

52. Vapalahti O, Lundkvist A, Kukkonen SKJ, et al. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol, 1996;77:3063–3067.

53. Zelená H, Mrázek J, Kuhn T. Tula hantavirus infection in immunocompromised host, Czech Republic. Emerg Infect Dis, 2013;19:1873–1876.

54. Schönrich G, Rang A, Lutteke N, et al. Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev, 2008;225:163–189.

55. Rasmuson J, Andersson C, Norrman E, et al. Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus. Eur J Clin Microbiol, 2011;30:685–690.

56. Chandy S, Abraham, P, Sridharan G. Hantaviruses: an emerging public health threat in India? A review. J Biosciencies, 2008;33:495–504.

57. Courouble P, Vanpee D, Delgrange E, et al. Hantavirus infections: clinical presentations in the emergency room. Eur J Emerg Med, 2001;8:17–20.

58. Pejčoch M, Kříž B. Hantaviry a jimi vyvolávaná onemocnění v České republice. Prakt lékař, 2007;87:545–549.

59. Park SC, Pyo HJ, Soe JB, et al. A clinical study of hemorrhagic fever with renal syndrome caused by Seoul virus infection. Korean J Intern Med, 1989;4:130–135.

60. MacNeil A, Nichol ST, Spiropoulou CF. Hantavirus pulmonary syndrome. Virus Res, 2011;162:138–147.

61. Korva M, Saksida A, Kejzar N, et al. Viral load and immune response dynamics in patients with haemorrhagic fever with renal syndrome. Clin Microbiol Infect, 2013;19:358–366.

61. Aitichou M, Saleh SS, McElroy AK, et al. Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR. J Virol Methods, 2005;124:21–26.

62. De Souza WM, Machado AM, Figueiredo LTM, et al. Serosurvey of hantavirus infection in humans in the border region between Brazil and Argentina. Rev Soc Bras Med Trop, 2011;44:131–135.

63. Clement J, Maes P, Van Ranst M. Hantaviruses in the Old and New world. In: Tabor E. Emerging Viruses in Human Populations. Amsterdam: Elsevier; 2007.

64. Lederer S, Lattwein E, Hanke M, et al. Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses. Plos Neglect Trop Dis, 2013;7:e2157.

65. Maes P, Keyaerts E, Li S, et al. Replication reduction neutralization test, a quantitative RT-PCR-based technique for the detection of neutralizing hantavirus antibodies. J Virol Methods, 2009;159:295–299.

66. Bi ZQ, Formenty PBH, Roth CE. Hantavirus Infection: A review and global update. J Infect Dev Ctries, 2008;2:3–23.

67. Hartline J, Mierek C, Knutson T, et al. Hantavirus infection in North America: a clinical review. Am J Emerg Med, 2013;31:978–982.

68. Dolgin E. Hantavirus treatments advance amidst outbreak in US park. Nat Med, 2012;18:1448.

69. Chu YK, Jennings GB, Schmaljohn CS. A vaccinia-virus vectored Hantaan and Seoul virus but not Puumala virus. J Virol, 1995;69:6417–6423.

70. Ulrich R, Koletzki D, Lachmann S, et al. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: Immunogenicity and protection against virus challenge. J Biotechnol, 1999;73:141–153.

71. Khattak S, Darai G, Sule S, et al. Characterization of expression of Puumala virus nucleocapsid protein in transgenic plants. Intervirology, 2002;45:334–339.

72. Razanskiene A, Schmidt J, Geldmacher A, et al. High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae. J Biotechnol, 2004;111:319–333.

73. Maes P, Clement J, Gavrilovskaya I, et al. Hantaviruses: Immunology, treatment, and prevention. Viral Immunol, 2004;17:481–497.

74. Vacková M, Beran J, Douda P, et al. Epidemiologická problematika hantavirových nákaz. Epidemiol Mikrobiol Imunol, 2000; 49:11–15.

75. Mace G, Feyeux C, Mollard N, et al. Severe Seoul hantavirus infection in a pregnant woman, France, October 2012. Eurosurveillance, 2013;18:14–17.

76. Daneš L. Přírodně ohniskové nákazy. Praha: Karolinum; 2003.